US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Antibody Technologies Market Research Reports & Industry Analysis

RSS Feeds

Antibody Technologies Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
China Monoclonal Antibodies Industry Report 2015
7/14/2015 | published by: QYResearch Group
... applications and industry chain structure. The Monoclonal Antibodies market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well ...  |  read more...
USD 3,200
Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application (Oncology, Blood Disorders) - Global Forecast to 2020
7/16/2015 | published by: MarketsandMarkets
... rise in demand for biopharmaceutical products such as biologics and biosimilars. Some of these factors include the rising pressure to reduce healthcare expenditure, growing demand for cost-effective alternatives, growing burden of chronic diseases, and growing ...  |  read more...
USD 4,650
Global Keyhole Limpet Hemocyanin Industry Report 2015
7/29/2015 | published by: QYResearch Group
... classifications, applications and industry chain structure. The Keyhole Limpet Hemocyanin market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed ...  |  read more...
USD 2,600
Global Monoclonal Antibodies Industry Report 2015
7/14/2015 | published by: QYResearch Group
... applications and industry chain structure. The Monoclonal Antibodies market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well ...  |  read more...
USD 2,800
Alzheimer’s Disease: Pharmacuetical Drugs Vs. Medicinal Plants-Markets, Competitors And Opportunities:2015-2020 Analysis And Forecasts
7/1/2015 | published by: Amadee + Company
... plants used to treat and prevent it. It also provides an overview of the leading companies serving this market and their current and future product offerings. This report will prove useful for people dealing with ...  |  read more...
USD 1,000
Antibodies in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... for the second wave in the lucrative field of therapeutic antibodies. There are today 490 companies plus partners developing 1039 antibody drugs in 2692 developmental projects in cancer. In addition, there are 6 suspended drugs ...  |  read more...
USD 6,750
Anti-CD19 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD19 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD19 Antibody- ...  |  read more...
USD 1,250
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD274 (PD-L1) Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Anti-CD28 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD28 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD28 Antibody- ...  |  read more...
USD 1,250
Anti-CD3 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD3 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD3 Antibody- ...  |  read more...
USD 1,250
Anti-CD30 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD30 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD30 Antibody- ...  |  read more...
USD 1,250
Anti-CD37 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD37 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD37 Antibody- ...  |  read more...
USD 1,250
Anti-CD4 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD4 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD4 Antibody- ...  |  read more...
USD 1,250
Anti-CD40 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD40 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD40 Antibody- ...  |  read more...
USD 1,250
Anti-CD6 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD6 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD6 Antibody- ...  |  read more...
USD 1,250
Anti-CD70 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD70 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD70 Antibody- ...  |  read more...
USD 1,250
Anti-CS1 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CS1 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CS1 Antibody- ...  |  read more...
USD 1,250
Anti-Dickkopf-1 (Dkk-1) Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-Dickkopf-1 (Dkk-1) Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Aurora A Kinase Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Aurora A Kinase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Conference Documentation: ADC Summit 2015
5/19/2015 | published by: SMI Publishing, Ltd
... payload of an ADC is critical. This conference goes to the heart of the technological challenges and asks: What does it take to develop superior ADCs and gain the clinical edge? Join us as we ...  |  read more...
USD 788.78
Next-Generation Antibody Therapies Market Forecast 2015-2025
5/15/2015 | published by: Visiongain
... revenues to 2025, assessing data, trends, opportunities and prospects there. Our 236-page report provides 126 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study ...  |  read more...
USD 2,788
Global Immunodiagnostics Industry 2015 Market Research Report
5/10/2015 | published by: 9Dimen Research
... the main countries (United States, Germany, Japan and China). The report firstly introduced the Immunodiagnostics basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so ...  |  read more...
USD 2,850
Global Immunoglobulin M Detection Kit Industry 2015 Market Research Report
5/18/2015 | published by: 9Dimen Research
... (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Immunoglobulin M Detection Kit basics: definitions, classifications, applications and industry chain overview; industry policies and ...  |  read more...
USD 2,850
Anti-CD22 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD22 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD22 Antibody- ...  |  read more...
USD 1,250
Anti-CD25 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD25 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD25 Antibody- ...  |  read more...
USD 1,250
< prev 1    3  4  5  6  7  8  9  10